On December 17, Gelonghui reported that Jianmin Pharmaceutical Group (600976.SH) announced that the Board of Directors approved its wholly-owned subsidiary Jianmin Pharmaceutical Group Yekai Thailand Co., Ltd. to invest 12.31 million yuan from its own funds to renovate the preprocessing building.
健民集团(600976.SH)：子公司拟1231万元对前处理大楼进行改造
Jianmin Pharmaceutical Group (600976.SH): A subsidiary plans to invest 12.31 million yuan to renovate the pre-processing building.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney